847
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Screening of Minor Benzo( c.)phenanthridine Alkaloids for Antiproliferative and Apoptotic Activities

, , , &
Pages 131-139 | Accepted 30 Aug 2006, Published online: 07 Oct 2008

References

  • Adhami VM, Aziz MH, Reagan-Shaw SR, Nihal M, Mukhtar H, Ahmad N (2004): Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Mol Cancer Ther 3: 933–940.
  • Ahmad N, Gupta S, Husain MM, Heiskanen KM, Mukhtar H (2000): Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res 6: 1524–1528.
  • Ansari KM, Dhawan A, Khanna SK, Das M (2005): In vivo DNA damaging potential of sanguinarine alkaloid, isolated from argemone oil, using alkaline Comet assay in mice. Food Chem Toxicol 43: 147–153.
  • Babich H, Zuckerbraun HL, Barber IB, Babich SB, Borenfreund E (1996): Cytotoxicity of sanguinarine chloride to cultured human cells from oral tissue. Pharmacol Toxicol 78: 397–403.
  • Chmura SJ, Dolan ME, Cha A, Mauceri HJ, Kufe DW, Weichselbaum RR (2000): In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo. Clin Cancer Res 6: 737–742.
  • Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F (1997): Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis). Cytometry 27: 1–20.
  • Das A, Mukherjee A, Chakrabarti J (2004): Sanguinarine: An evaluation of in vivo cytogenetic activity. Mutat Res Genet Toxicol Environ Mutagen 563: 81–87.
  • Debiton E, Madelmont JC, Legault J, Barthomeuf C (2003): Sanguinarine-induced apoptosis is associated with an early and severe cellular glutathione depletion. Cancer Chemother Pharmacol 51: 474–482.
  • Dostál J, Potáček M (1990): Qaternary benzo(c)phenanthridine alkaloids. Coll Czech Chem Commun 55: 2840–2873.
  • Herbert JM, Augerau JM, Gleye J, Maffrand JP (1990): Chelerythrine is a potent and specific inhibitor of protein-kinase-C. Biochem Biophys Res Commun 172: 993–999.
  • Ishikawa T, Saito T, Ishii H (1995): Synthesis of macarpine and its cytotoxicity—toward the synthetic route for 12-alkoxybenzo[c]phenanthridine alkaloids through aromatic nitrosatin under basic conditions. Tetrahedron 51: 8447–8458.
  • Kovář J, Šimek K, Kožoušková E, Klukanová H, Slavík J (1985): Fluorescence properties of some isoquinoline alkaloids. Coll Czech Chem Commun 50: 1312–1328.
  • Miura N, Yamamoto M, Ueki T, Kitani T, Fukuda K, Komatsu Y (1997): Inhibition of thymocyte apoptosis by berberine. Biochem Pharmacol 53: 1315–1322.
  • Nakanishi M, Suzuki T, Saimoto A, Kabasawa T (1999): Structural considerations of NK109, an antitumor benzo[c]phenanthridine alkaloid. J Nat Prod 62: 864–867.
  • Panzer A, Hamel E, Joubert AM, Bianchi PC, Seegers JC (2000): Ukrain (TM) a semisynthetic Chelidonium majus alkaloid derivative, acts by inhibition of tubulin polymerization in normal and malignant cell lines. Cancer Lett 160: 149–157.
  • Saran A, Srivastava S, Countinho E, Maiti M (1995): H-1-NMR investigation of the interaction of berberine and sanguinarine with DNA. Indian J Biochem Biophys 32: 74–77.
  • Schmeller T, LatzBruning B, Wink M (1997): Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores. Phytochemistry 44: 257–266.
  • Šimánek V (1985): Benzophenanthridine alkaloids. In: Brossi A, ed., The Alkaloids, Vol 26. Orlando, Academic Press, pp. 185–240.
  • Šimánek V, Vespalec R, Šedo A, Ulrichová J, Vičar J (2003): Quaternary benzo(c)phenanthridine alkaloids—biological activities. In: Schneider MP, ed., Chemical Probes in Biology. Netherlands, Kluwer Academic Publishers, pp. 245–254.
  • Simeon S, Rios JL, Villar A (1989): Pharmacological activities of benzophenanthridine and phenanthrene alkaloids. Pharmazie 44: 593–597.
  • Singh R, Faridi MMA, Singh K, Siddiqui R, Bhatt N, Karna S (1999): Epidemic dropsy in the eastern region of Nepal. J Trop Pediatr 45: 8–13.
  • Slaninová I, Táborská E, Bochořáková H, Slanina J (2001): Interaction of benzo [c] phenanthridine and protoberberine alkaloids with animal and yeast cells. Cell Biol Toxicol 17: 51–63.
  • Slavík J (1961): Alkaloide der mohngewächse (Papaveraceae) XX. Über die alkaloide aus Stylophorum diphyllum (Michx.) Nutt. Coll Czech Chem Commun 26: 2933–2939.
  • Slavík J, Hanuš V, Slavíková L (1991): Alkaloids of the Papaveraceae. 91. Alkaloids from Stylophorum-Lasiocarpum (Oliv) Fedde. Coll Czech Chem Commun 56: 1116–1122.
  • Slavík J, Slavíková L (1960): Alkaloide der mohngewächse (Papaveraceae) XVII. Über neue alkaloide aus Sanguinaria canadensis L. Coll Czech Chem Commun 25: 1667–1675.
  • Stiborová M, Šimánek V, Frei E, Hobza P, Ulrichová J (2002): DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as related by P32 postlabelling technique. Chem Biol Interact 140: 231–242.
  • Táborská E, Věžník F, Slavíková L, Slavík J (1978): Quaternary alkaloids of three species of Dicranostigma Hook. F. et Thoms. Coll Czech Chem Commun 43: 1108–1112.
  • Toušek J, Dostál J, Slaninová I, Táborská E (2005): A quantum chemical study vs. biological activity of seven quaternary benzophenanthridine alkaloids. In: Potáček M, Dostál J, eds., Book of Abstrakts of 11th Blue Danube Symposium on Heterocyclic Chemistry. PO-18, Brno, Masaryk University.
  • Ulrichová J, Dvořák Z, Vičar J, Lata J, Smržová J, Šedo A, Šimánek V (2001): Cytotoxicity of natural compounds in hepatocyte cell culture models—the case of quaternary benzo[c]phenanthridine alkaloids. Toxicol Lett 125: 125–132.
  • Ulrichová J, Walterová D, Vavrečková C, Kamarád V, Šimánek V (1996): Cytotoxicity of benzo[c]phenanthridinium alkaloids in isolated rat hepatocytes. Phytother Res 10: 220–223.
  • Vavrečková C, Gawlik I, Muller K (1996): Benzophenanthridine alkaloids of Chelidonium majus. 2. Potent inhibitory action against the growth of human keratinocytes. Planta Med 62: 491–494.
  • Vavrečková C, Ulrichová J (1994): Biological activity of quaternary benzo[c]phenanthridine alkaloids—sanguinarine and chelerythrine. Chemicke-listy 88: 238–248.
  • Vespalec R, Barták P, Šimánek V, Vlčková M (2003): Electrophoretic investigation of interactions of sanguinarine and chelerythrine with molecules containing mercapto group. J Chromatogr B 797: 357–366.
  • Vlčková M, Barták P, Kubáň V (2004): Capillary electrophoretic studies of acid–base properties of sanguinarine and chelerythrine alkaloids. J Chromatogr A 1040: 141–145.
  • Vlčková M, Kubáň V, Vičar J, Šimánek V (2005): Capillary zone electrophoretic studies of interactions of some quaternary isoquinoline alkaloids with DNA constituents and DNA. Electrophoresis 26: 1673–1679.
  • Walterová D, Ulrichová J, Válka I, Vičar J, Vavrečková C, Táborská E, Harkrader RJ, Meyer DL, Černá H, Šimánek V (1995): Benzo(c)phenanthridine alkaloids sanguinarine and chelerythrine: Biological activities and dental care applications. Acta Univ Palacki Olomouc Fac Med 139: 7–14.
  • Weerasinghe P, Hallock S, Tang SC, Liepins A (2001a): Role of Bcl-2 family proteins and caspase-3 in sanguinarine-induced bimodal cell death. Cell Biol Toxicol 17: 371–381.
  • Weerasinghe P, Hallock S, Tang SC, Liepins A (2001b): Sanguinarine induces bimodal cell death in K562 but not in high Bcl-2-expressing JM1 cells. Pathol Res Pract 197: 717–726.
  • Yamamoto S, Seta K, Morisco C, Vatner SF, Sadoshima J (2001): Chelerythrine rapidly induces apoptosis through generation of reactive oxygen species in cardiac myocytes. J Mol Cell Cardiol 33: 1829–1848.
  • Yu R, Mandlekar S, Tan TH, Kong ANT (2000): Activation of p38 and c-Jun N-terminal kinase pathways and induction of apoptosis by chelerythrine do not require inhibition of protein kinase C. J Biol Chem 275: 9612–9619.55.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.